{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:11:27Z","timestamp":1761581487933},"reference-count":30,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009550","name":"Hasselt University","doi-asserted-by":"crossref","award":["BOF11NI31 to SA"],"award-info":[{"award-number":["BOF11NI31 to SA"]}],"id":[{"id":"10.13039\/501100009550","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.072","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T15:15:20Z","timestamp":1478790920000},"page":"6187-6192","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inferring rubella outbreak risk from seroprevalence data in Belgium"],"prefix":"10.1016","volume":"34","author":[{"given":"Steven","family":"Abrams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Kourkouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Sabbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Beutels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niel","family":"Hens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.10.072_b0005","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)15897-2","article-title":"Rubella","volume":"363","author":"Banatvala","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.10.072_b0010","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/S0264-410X(02)00335-3","article-title":"The difficult quest for data on \u201cvanishing\u201d vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium)","volume":"20","author":"Beutels","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.072_b0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3201\/eid1903.121360","article-title":"Measles elimination efforts and 2008\u20132011 outbreak, France","volume":"19","author":"Antona","year":"2013","journal-title":"Emerg Infect Diseases"},{"key":"10.1016\/j.vaccine.2016.10.072_b0020","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3201\/eid1910.130258","article-title":"Ongoing measles outbreak in Orthodox Jewish community, London, UK","volume":"19","author":"Baugh","year":"2013","journal-title":"Emerg Infect Diseases"},{"key":"10.1016\/j.vaccine.2016.10.072_b0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/0778-7367-71-17","article-title":"Obstacles in measles elimination: an in-depth description of a measles outbreak in Ghent, Belgium, spring 2011","volume":"71","author":"Braeye","year":"2013","journal-title":"Arch Public Health"},{"key":"10.1016\/j.vaccine.2016.10.072_b0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3201\/eid1301.060649","article-title":"Vaccine effectiveness estimates, 2004\u20132005 mumps outbreak, England","volume":"13","author":"Cohen","year":"2007","journal-title":"Emerg Infect Diseases"},{"key":"10.1016\/j.vaccine.2016.10.072_b0035","article-title":"Mumps outbreak among university students in 2012 [in Dutch]","author":"Flipse","year":"2013","journal-title":"Vlaams Infectiebulletin"},{"key":"10.1016\/j.vaccine.2016.10.072_b0040","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60712-1","article-title":"Rubella outbreak in Japan","volume":"383","author":"Ujiie","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.10.072_b0045","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.21.20485-en","article-title":"Ongoing outbreak of rubella among young male adults in Poland: increased risk of congenital rubella infections","volume":"18","author":"Paradowska-Stankiewicz","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.10.072_b0050","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.07.20089-en","article-title":"Ongoing rubella outbreak among adolescents in Salaj, Romania, September 2011-January 2012","volume":"17","author":"Janta","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.10.072_b0055","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199411243312101","article-title":"The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program","volume":"331","author":"Peltola","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.10.072_b0060","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kwu014","article-title":"Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data","volume":"179","author":"Abrams","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.10.072_b0065","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2015.20.1.20998","article-title":"Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013","volume":"20","author":"Hens","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.10.072_b0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1017\/S0950268810001536","article-title":"Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium","volume":"139","author":"Theeten","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.10.072_b0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2016.10.072_b0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2334-9-187","article-title":"Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eights European countries","volume":"9","author":"Hens","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.072_b0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1467-9876.2009.00693.x","article-title":"Estimating infectious disease parameters from data on social contacts and serological status","volume":"59","author":"Goeyvaerts","year":"2010","journal-title":"J R Stat Soc Series C"},{"key":"10.1016\/j.vaccine.2016.10.072_b0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/EDE.0000000000000278","article-title":"Estimating vaccine coverage from serial trivariate serologic data in the presence of waning immunity","volume":"26","author":"Wood","year":"2015","journal-title":"Epidemiol"},{"key":"10.1016\/j.vaccine.2016.10.072_b0095","series-title":"Vaccines","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.vaccine.2016.10.072_b0100","series-title":"Generalized additive models","author":"Hastie","year":"1990"},{"key":"10.1016\/j.vaccine.2016.10.072_b0105","series-title":"Generalized additive models: an introduction with R","author":"Wood","year":"2006"},{"key":"10.1016\/j.vaccine.2016.10.072_b0110","series-title":"2nd international symposium on information theory","first-page":"267","article-title":"Information theory and an extension of the maximum likelihood principle","author":"Akaike","year":"1973"},{"key":"10.1016\/j.vaccine.2016.10.072_b0115","series-title":"Infectious diseases of humans; dynamics and control","author":"Anderson","year":"1991"},{"key":"10.1016\/j.vaccine.2016.10.072_b0120","series-title":"Modeling epidemics","author":"Farrington","year":"2003"},{"key":"10.1016\/j.vaccine.2016.10.072_b0125","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2010.06.004","article-title":"Kinetics of maternal antibodies against rubella and varicella in infants","volume":"29","author":"Leuridan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.072_b0130","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/sim.6518","article-title":"Multi-disease analysis of maternal antibody decay using non-linear mixed models accounting for censoring","volume":"34","author":"Goeyvaerts","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2016.10.072_b0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00006454-199507000-00004","article-title":"High incidence of congenital rubella syndrome after a rubella outbreak","volume":"14","author":"Mellinger","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.10.072_b0140","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.10.072_b0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcv.2006.12.017","article-title":"Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests","volume":"38","author":"Tischer","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2016.10.072_b0150","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/sim.4481","article-title":"Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological data","volume":"31","author":"Goeyvaerts","year":"2012","journal-title":"Stat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T01:54:53Z","timestamp":1657677293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16310222"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inferring rubella outbreak risk from seroprevalence data in Belgium","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}